Vascular Solutions (VASC) Tops Q4 EPS by 6c; Guides Q1 EPS Below Expectations

Vascular Solutions (NASDAQ: VASC) reported Q4 EPS of $0.33, $0.06 better than the analyst estimate of $0.27. Revenue for the quarter came in at $38.1 million versus the consensus estimate of $37.54 million.

GUIDANCE:

Vascular Solutions sees Q1 2016 EPS of $0.22-$0.24, versus the consensus of $0.26. Vascular Solutions sees Q1 2016 revenue of $38-39 million, versus the consensus of $38.1 million.

Vascular Solutions sees FY2016 EPS of $1.17-$1.21, versus the consensus of $1.17. Vascular Solutions sees FY2016 revenue of $161-165 million, versus the consensus of $163.9 million.

For earnings history and earnings-related data on Vascular Solutions (VASC) click here.

You May Also Be Interested In

• General Motors (GM) Tops Q1 EPS by 50c, Raises Guidance
• Pinnacle Financial Partners (PNFP) Tops Q1 EPS by 3c; offers outlook
• JPMorgan is worried about further S&P 500 sell-off potential